Form 4: Columbia Financial Executive Increases Holdings Through Stock-Based Deferral Plan
SEC Form 4 Filing
Allyson Katz Schlesinger, a senior executive at Columbia Financial, has increased her indirect holdings of company stock through a stock-based deferral plan.
Summary
- Allyson Katz Schlesinger, SEVP & Head of Consumer Banking at Columbia Financial, Inc., reported a transaction on November 29, 2024.
- She acquired 17,722.4 shares of common stock indirectly through a stock-based deferral plan at a price of $18.23 per share.
- Following this transaction, her total holdings include 62,607 shares directly, and 5,514 shares through an ESOP, 5,854 through a SERP, 4,683 through a SIM, 15,917 through Stock Award II, and 13,824 through Stock Award III.
- She also holds stock options to purchase 155,294 shares at $15.60, 12,632 shares at $15.94, and 9,292 shares at $16.49.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction, but the executive's increased investment is a positive sign. The sentiment is neutral to slightly positive.
Positives
- The executive's increased investment in the company may signal confidence in its future performance.
- The stock-based deferral plan allows for tax-advantaged accumulation of company stock.
Industry Context
This filing is a routine disclosure of insider transactions, which is common in the financial industry. It provides transparency into the holdings of company executives.
Comparison to Industry Standards
- Stock-based compensation and deferral plans are common practices in the financial industry to align executive interests with shareholder value.
- The vesting schedules for stock awards and options are typical for executive compensation packages in comparable financial institutions.
- The reported transactions are consistent with standard SEC Form 4 filings for changes in beneficial ownership.
Stakeholder Impact
- The transaction may have a slightly positive impact on shareholder confidence due to the executive's increased investment.
Key Dates
| Date | Description |
|---|---|
| 07/23/2020 | Date of grant for stock options exercisable at $15.60. |
| 05/01/2024 | Date of grant for stock options exercisable at $15.94 and commencement of vesting for Stock Award II. |
| 11/29/2024 | Date of the reported stock acquisition through the deferral plan. |
| 03/06/2025 | Commencement of vesting for Stock Award III and date of grant for stock options exercisable at $16.49. |
Keywords
stock-based deferral plan, insider trading, stock options, equity incentive plan, common stock, Columbia Financial, CLBK, executive compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.